Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes.
Authors
Purohit, SharadPodolsky, Robert H.
Collins, Christin
Zheng, Weipeng
Schatz, Desmond
Muir, Andy
Hopkins, Diane
Huang, Yi-Hua
She, Jin-Xiong
Issue Date
2005-11-24
Metadata
Show full item recordAbstract
BACKGROUND: Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) plays a critical role in downregulation of antigen-activated immune response and polymorphisms at the CTLA-4 gene have been shown to be associated with several autoimmune diseases including type-1 diabetes (T1D). The etiological mutation was mapped to the CT60-A/G single nucleotide polymorphism (SNP) that is believed to control the processing and production of soluble CTLA-4 (sCTLA-4). METHODS: We therefore determined sCTLA-4 protein levels in the sera from 82 T1D patients and 19 autoantibody positive (AbP) subjects and 117 autoantibody negative (AbN) controls using ELISA. The CT-60 SNP was genotyped for these samples by using PCR and restriction enzyme digestion of a 268 bp DNA segment containing the SNP. Genotyping of CT-60 SNP was confirmed by dye terminating sequencing reaction. RESULTS: Higher levels of sCTLA-4 were observed in T1D (2.24 ng/ml) and AbP (mean = 2.17 ng/ml) subjects compared to AbN controls (mean = 1.69 ng/ml) with the differences between these subjects becoming significant with age (p = 0.02). However, we found no correlation between sCTLA-4 levels and the CTLA-4 CT-60 SNP genotypes. CONCLUSION: Consistent with the higher serum sCTLA-4 levels observed in other autoimmune diseases, our results suggest that sCTLA-4 may be a risk factor for T1D. However, our results do not support the conclusion that the CT-60 SNP controls the expression of sCTLA-4.Citation
J Autoimmune Dis. 2005 Oct 31; 2:8ae974a485f413a2113503eed53cd6c53
10.1186/1740-2557-2-8
Scopus Count
Related articles
- CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden.
- Authors: Mayans S, Lackovic K, Nyholm C, Lindgren P, Ruikka K, Eliasson M, Cilio CM, Holmberg D
- Issue date: 2007 Feb 6
- Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
- Authors: Daroszewski J, Pawlak E, Karabon L, Frydecka I, Jonkisz A, Slowik M, Bolanowski M
- Issue date: 2009 Nov
- The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
- Authors: Torres-Carrillo N, Ontiveros-Mercado H, Torres-Carrillo NM, Parra-Rojas I, Rangel-Villalobos H, Ramírez-Dueñas MG, Gutiérrez-Ureña SR, Valle Y, Muñoz-Valle JF
- Issue date: 2013
- Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes.
- Authors: Momin S, Flores S, Angel B B, Codner D E, Carrasco P E, Perez-Bravo F
- Issue date: 2009 Mar
- The role of cytotoxic T-Lymphocyte antigen-4+49A/G gene polymorphism in cutaneous leishmaniasis.
- Authors: Al-Ghabban MJS, Al-Bayati NY, Al-Mayah QS, Al-Matubsi HY
- Issue date: 2021 Sep